Salmonella enterica is a single bacterial species responsible for an astonishing range of illness, from the self-limiting stomach bug you get from undercooked chicken to typhoid fever, a life-threatening systemic infection that kills hundreds of thousands of people a year. The difference comes down to which variant, or serovar, infects you: nontyphoidal serovars cause roughly 100 million infections and over 200,000 deaths annually worldwide, mostly through gastroenteritis, while the human-restricted typhoidal serovars cause a systemic disease with a mortality rate reaching 30 percent if untreated.1Trends in Microbiology. Salmonella Enterica: Food Poisoning to Typhoid Fever How one species learned to play both roles is a story that spans molecular trickery, immune evasion, and an increasingly urgent crisis of antibiotic resistance.
One Species, Many Diseases
Salmonella enterica contains six recognized subspecies, but subspecies I (subspecies enterica) is the one that matters for human health. It accounts for nearly all Salmonella infections in people and other warm-blooded animals.2PubMed Central. Evolutionary Genomics of Salmonella enterica Subspecies The other five subspecies mostly turn up in cold-blooded animals and rarely trouble humans. Within subspecies I alone there are more than 2,300 known serovars, yet only a handful cause the overwhelming majority of infections in people and livestock.3PubMed Central. Characterization of Salmonella enterica subspecies I genovars by use of microarrays
The serovars that most people encounter fall into two broad camps. Nontyphoidal serovars like Typhimurium and Enteritidis infect a wide range of hosts and typically cause gastroenteritis: diarrhea, cramps, and fever lasting a few days. Typhoidal serovars, principally Typhi and Paratyphi A, have narrowed their host range to humans alone and cause typhoid or paratyphoid fever, a systemic infection that can persist for weeks. That host restriction is a clue to how deeply the typhoidal serovars have adapted to human biology. They have shed some of the genes their nontyphoidal relatives use to provoke gut inflammation and instead acquired tools for silent spread through the bloodstream.
How Salmonella Breaks Into Your Cells
The initial invasion of intestinal cells relies on a molecular syringe known as a type III secretion system, encoded by a cluster of genes called Salmonella Pathogenicity Island 1, or SPI-1. This system punches a needle-like structure through the membrane of an intestinal cell and injects proteins, called effectors, directly into the cell’s interior. Those effectors hijack the cell’s own scaffolding: they activate signaling molecules that trigger the cell to ruffle its membrane and essentially engulf the bacterium.4PubMed Central. Salmonella Pathogenicity Island 1 (SPI-1) and Its Complex Regulatory Network Experiments have shown that just a few of these injected proteins are enough on their own to make invasion happen. Two of them, SopE and SopE2, flip molecular switches inside the host cell that cause the dramatic membrane ruffling and bacterial uptake.5PLoS Pathogens. Minimal SPI1-T3SS effector requirement for Salmonella enterocyte invasion and intracellular proliferation in vivo
Once inside, Salmonella faces a second challenge: surviving the immune cell that swallows it. Here, a different gene cluster, SPI-2, takes over. SPI-2 is switched on after the bacterium is already inside a cell and is essential for survival within macrophages, the immune cells whose job is to destroy invaders.6PubMed. Taking possession: biogenesis of the Salmonella-containing vacuole One of SPI-2’s key tricks is to block the delivery of toxic nitrogen compounds to the compartment where the bacterium sits. Normally, macrophages flood that compartment with reactive nitrogen species to kill whatever is trapped inside. Salmonella uses SPI-2 effectors to divert those toxic molecules away, essentially redecorating its prison cell into a safe house.7PubMed Central. Salmonella Pathogenicity Island 2 Mediates Protection of Intracellular Salmonella from Reactive Nitrogen Intermediates
Nontyphoidal Salmonella and Ordinary Food Poisoning
For most people in higher-income countries, a Salmonella infection means a few miserable days of watery diarrhea, abdominal cramps, and fever starting 12 to 72 hours after eating contaminated food. Nontyphoidal serovars achieve this by actively penetrating the intestinal lining and triggering a strong inflammatory cascade. The body’s innate immune system detects bacterial components like flagellin and cell-wall molecules through pattern-recognition receptors, which activate inflammasomes and recruit waves of immune cells to the gut wall.8PubMed. Inflammasome activation by Salmonella That inflammatory response is what produces the diarrhea: it is the body flushing bacteria out, collateral damage from its own defenses.
A healthy gut microbiome offers a first line of defense before the immune system even gets involved. Certain resident bacteria, particularly species of Bacteroides, produce short-chain fatty acids like propionate that directly inhibit Salmonella growth by disrupting its internal pH. In mouse studies, experimentally increasing propionate levels in the gut protected animals from Salmonella colonization.9Cell Host & Microbe. Bacteroides-Derived Propionate Mediates Colonization Resistance against Salmonella Typhimurium in the Gut This colonization resistance is one reason antibiotic use can paradoxically make you more vulnerable to Salmonella: wiping out protective gut bacteria removes the chemical barrier that keeps the pathogen in check.
In healthy adults, nontyphoidal Salmonella gastroenteritis usually resolves without antibiotics. But the picture changes dramatically in vulnerable populations. In sub-Saharan Africa, nontyphoidal Salmonella frequently escapes the gut and enters the bloodstream, causing what is known as invasive nontyphoidal Salmonella (iNTS) disease. The most important risk factors are HIV infection in adults, and malaria, HIV, and malnutrition in children.10PubMed Central. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa A distinct lineage of Salmonella Typhimurium, called ST313, has emerged in the region and appears to have adapted to cause this bloodstream form of disease. The odds of developing iNTS disease in HIV-positive individuals compared to uninfected people range from about three-fold to more than 48-fold, depending on the study. For malaria, the odds run roughly 1.5 to four times higher in infected individuals.11PLoS Neglected Tropical Diseases. A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014) Young age and severe anemia are additional risk factors, with sickle cell disease also strongly associated.12PubMed Central. Invasive Nontyphoidal Salmonella Disease in Africa
How Typhoid Fever Differs
Typhoid fever is a fundamentally different kind of illness. Instead of provoking explosive gut inflammation, Salmonella Typhi slips through the intestinal lining relatively quietly and hitches a ride inside immune cells to reach the liver, spleen, bone marrow, and lymph nodes. The mesenteric lymph nodes, which drain the intestines, serve as a crucial firewall: in mouse studies, surgically removing them allowed far more bacteria to reach distant organs and turned normally resistant animals into fatally susceptible ones.13PubMed Central. Mesenteric lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar Typhimurium and limit systemic disease in mice When the lymph nodes fail to contain the bacteria, the result is the sustained high fever, headache, and sometimes a faint rash on the trunk that characterize typhoid.
Salmonella Typhi also deploys a weapon its nontyphoidal cousins lack: typhoid toxin. This toxin comes in two forms, each using a different receptor-binding subunit (PltB and PltC) to target different tissues. Recent research has shown that the PltC form has a particular affinity for liver cells and gallbladder tissue, binding to sulfated sugars on their surfaces.14PubMed Central. Molecular basis of the hepatobiliary tropism of typhoid toxin promoting Salmonella pathogenicity This targeting helps explain why the liver and gallbladder are central to both acute typhoid fever and the chronic carrier state.
The most feared complication of typhoid is intestinal perforation, where the bacteria erode through the wall of the small intestine. Rates vary enormously depending on setting: perforation is documented in anywhere from under 1 percent to as high as 39 percent of cases, with the stark discrepancy largely reflecting differences in access to early antibiotic treatment. Mortality from typhoid intestinal perforation in resource-poor settings still ranges from 5 to 80 percent.15PubMed Central. Typhoid intestinal perforation in developing countries: Still unavoidable deaths? Case reports from developing countries describe extreme scenarios, including a patient with 24 separate perforations.16PubMed Central. Typhoid intestinal perforation: 24 perforations in one patient
Chronic Carriers and the Gallbladder
Some people recover from typhoid fever but never fully clear the bacteria. In a subset of individuals, Salmonella Typhi quietly colonizes the gallbladder, establishing an asymptomatic chronic infection that can persist for years or even a lifetime. These carriers shed bacteria in their stool and can unknowingly spread disease, a phenomenon famously illustrated by the historical case of “Typhoid Mary.” The key to this persistence is biofilm: the bacteria form dense, sticky communities on the surface of gallstones, which act as a platform for long-term colonization.17PubMed Central. Gallbladder epithelium as a niche for chronic Salmonella carriage
Research in both humans and mice has confirmed the gallstone connection. In a study of patients with gallstones in typhoid-endemic Mexico City, 5 percent of those undergoing gallbladder removal were found to be carrying Salmonella Typhi, with visible biofilms on the gallstones. Mice fed a diet that induced gallstone formation showed enhanced bacterial colonization and fecal shedding during persistent infection compared to mice without stones.18PubMed Central. Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage This is why cholecystectomy (gallbladder removal) has historically been used to cure chronic typhoid carriers who fail antibiotic therapy.
The chronic carrier state also has a darker long-term consequence. Epidemiological studies in regions where Salmonella Typhi is endemic have found that chronic carriers with gallstones face an elevated risk of gallbladder cancer. The suspected mechanism involves sustained local inflammation from the biofilm, combined with repeated exposure to carcinogenic bacterial toxins on the gallbladder lining.19PubMed Central. Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer
The Food Chain Problem
For nontyphoidal serovars, contaminated food, especially poultry and eggs, remains the primary route into humans. The bacteria can travel through the entire poultry production chain: Salmonella Enteritidis infection can begin at the breeding stage and spread both vertically (from hen to egg) and horizontally (from bird to bird) along the way.20PubMed Central. Prevalence and transmission of Salmonella collected from farming to egg processing of layer production chain in Jiangsu Province, China In experimental settings, about 60 percent of in-contact hens became infected from inoculated hens, and close to 60 percent of eggs from infected flocks tested positive for Salmonella on the eggshell. Vertical transmission into the egg’s contents happened about 5 percent of the time.21PubMed Central. Assessment of foodborne transmission of Salmonella enteritidis in hens and eggs in Bangladesh
Controlling Salmonella in poultry is therefore a multi-stage problem. Effective strategies combine biosecurity measures on the farm, vaccination of flocks against the most common pathogenic serovars, feed management, and post-harvest interventions like antimicrobial carcass washes and sanitation in processing plants.22PubMed Central. A Mini-Review on Multi-Hurdle Control of Salmonella Along Poultry Production Continuum Vaccination of broiler flocks with a live Salmonella Typhimurium vaccine has been shown to reduce the risk of gut colonization significantly, cutting positive birds by roughly 35 per 1,000 compared to unvaccinated controls.23Food Research International. A systematic review and meta-analysis of the effectiveness of biosecurity and vaccination in reducing Salmonella spp. in broiler chickens No single intervention eliminates the bacteria, which is why the “multi-hurdle” approach, layering several imperfect barriers, remains the industry standard.
Antibiotic Resistance and the Rise of XDR Typhoid
Perhaps the most alarming recent development in the Salmonella story is the emergence of extensively drug-resistant (XDR) typhoid. In 2016, an outbreak emerged in Sindh Province, Pakistan, caused by a Salmonella Typhi clone resistant not only to the three traditional first-line antibiotics (chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole) but also to fluoroquinolones and third-generation cephalosporins. That left only a single widely available oral antibiotic, azithromycin, as a treatment option. Whole-genome sequencing of more than 80 of these XDR isolates revealed remarkable genetic uniformity: they all belonged to a single lineage called H58 and carried resistance genes both on a plasmid and embedded in their chromosome.24PubMed Central. Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins
Since that initial emergence, XDR Typhi has been identified in other parts of Pakistan and in travelers returning to other countries. The resistance plasmids involved carry multiple replicons and can transfer between bacterial species, raising the specter of resistance spreading to other pathogens in the gut.22PubMed Central. A Mini-Review on Multi-Hurdle Control of Salmonella Along Poultry Production Continuum If azithromycin resistance follows, typhoid in affected regions could become functionally untreatable with oral drugs, a prospect that has accelerated interest in both vaccines and alternative therapies.
Typhoid Conjugate Vaccines
The rising threat of drug resistance has made vaccination against typhoid fever more urgent than ever. The newer typhoid conjugate vaccines (TCVs), which link the Vi polysaccharide from Salmonella Typhi’s capsule to a protein carrier, are a significant advance over older polysaccharide-only vaccines because they work in young children and produce longer-lasting immunity. In a phase 3 trial in Malawi that followed children for a median of about four years, a single dose of Vi-TCV showed roughly 80 percent efficacy in preventing blood-culture-confirmed typhoid fever.25PubMed Central. Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children That protection held up well over time: the final four-year analysis confirmed about 78 percent efficacy in the full intention-to-treat population.26The Lancet. Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children
Real-world effectiveness appears consistent with the trial results. A field evaluation of a large-scale public-sector vaccination campaign in Navi Mumbai, India, found vaccine effectiveness of about 84 percent among vaccinated children.27PubMed Central. Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign Several countries in South Asia and sub-Saharan Africa have now introduced TCVs into routine childhood immunization programs, and the WHO has recommended their use in typhoid-endemic areas.
Phage Therapy and New Tools Against Resistance
Beyond vaccines, researchers are exploring bacteriophages, viruses that infect and kill bacteria, as an alternative to antibiotics for drug-resistant Salmonella. Phages have a built-in advantage: they target specific bacterial hosts and leave human cells and beneficial gut bacteria untouched. Experimental studies in poultry have already demonstrated the safety and efficacy of phage cocktails for reducing Salmonella colonization, and there is growing interest in phage therapy for human infections where antibiotics are failing.28PubMed Central. Use of Phages to Treat Antimicrobial-Resistant Salmonella Infections in Poultry Phages remain an experimental approach in humans, and the regulatory path is still being worked out, but the concept has moved well past theoretical.
On the detection side, new biosensor technologies are aiming to shrink the time it takes to identify Salmonella in food. Traditional culture-based methods can take several days. A biosensor platform recently tested on meat samples achieved detection of Salmonella within 24 hours at concentrations as low as 10 bacterial cells per gram, with accuracy ranging from 80 to about 90 percent depending on the food substrate.29PubMed Central. A Novel Application of B.EL.D™ Technology: Biosensor-Based Detection of Salmonella spp. in Food Faster detection in processing facilities could allow contaminated batches to be caught before reaching consumers.
Salmonella as a Cancer-Fighting Tool
In one of the stranger twists in microbiology, the same features that make Salmonella enterica a dangerous pathogen have attracted interest from cancer researchers. Attenuated (weakened) strains of Salmonella have a natural tendency to accumulate in tumor tissue, drawn by the low-oxygen, nutrient-rich, immune-suppressed environment that tumors create. Once inside a tumor, the bacteria can kill cancer cells directly and provoke the immune system to attack the tumor.30PubMed Central. Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
Researchers have gone further, engineering attenuated Salmonella to carry therapeutic cargo: tumor antigens that train the immune system, cytokines that boost the anti-tumor response, or even pro-apoptotic proteins that trigger cancer cell death. In animal studies with melanoma, a single oral dose of Salmonella carrying cytokine-encoding genes significantly extended survival compared to controls.31PubMed. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma The bacteria essentially act as a delivery truck, using their natural cell-invasion machinery to deposit therapeutic molecules inside tumor cells through a process sometimes called bactofection.32PubMed Central. Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy This work is still in preclinical and early clinical stages, but it illustrates how deeply researchers have come to understand Salmonella’s cellular machinery, and how that understanding can be redirected toward entirely different problems.